Referências
Sampaio LP, Hilgert GSL, Shiju TM, Santhiago MR, Wilson SE. Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Alkali Burns in Rabbits. Exp Eye Res. 2022;220:109097. PubMed PMID: 35490835.
Pereira-Souza AL, Ambrósio R Jr, Bandeira F, Salomão MQ, Souza-Lima A, Wilson SE. Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience. J Refract Surg. 2022;38(11):722-729. PubMed PMID: 36367246.
Santhiago MR, Sampaio LP, Wilson SE. Topical losartan for the treatment of corneal fibrosis in vivo in rabbits. Exp Eye Res. 2023;233:109533. PubMed PMID: 37315639.
Tan DT, Dart JK, Holland EJ, Kinoshita S. Corneal transplantation. Lancet. 2012;379(9827):1749-1761. PubMed PMID: 22559901.
Reinhart WJ, Musch DC, Jacobs DS, et al. Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty — a report by the American Academy of Ophthalmology. Ophthalmology. 2011;118(1):209-218. PubMed PMID: 21070783.
Alio JL, Rodriguez AE, El Bahrawy M, Angelov A, Zein G. Keratopigmentation to change the apparent color of the human eye: a novel indication for corneal tattooing. Cornea. 2016;35(4):431-437. PubMed PMID: 26807905.
Sirerol B, Walewska-Szafran A, Alio JL, Klonowski P, Abu Mustafa SK. Tolerance and biocompatibility of micronized black pigment for keratopigmentation simulated pupil reconstruction. Cornea. 2011;30(3):344-350. PubMed PMID: 21099414.
American Academy of Ophthalmology — EyeWiki. Corneal Opacity.
American Academy of Ophthalmology — EyeWiki. Corneal Tattooing / Keratopigmentation.